Journal for ImmunoTherapy of Cancer
@jitcancer
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD
ID: 1150769339466952705
https://jitc.bmj.com/ 15-07-2019 14:09:25
5,5K Tweet
8,8K Followers
1,1K Following
New #JITC article: Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors bit.ly/3AayIPM Rachel E. Sanborn, MD Dr. Julie Brahmer
